Reumuth Mary
SEC CIK 1710969 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| KALA | KALA BIO, Inc. | CFO | 29.9K | — | $129.4K | 17 | 2021-10-26 | 2025-10-22 |
Most active insiders at KALA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | BAKER JULIAN | Former 10% owner | — | $1.06M |
| 2 | Iwicki Mark T | Dir | — | $125.5K |
| 3 | Bazemore Todd | Dir | — | $39.6K |
| 4 | Brazzell Romulus K | SEE REMARKS | — | $38.8K |
| 5 | Reumuth Mary | CFO | — | $27.5K |
| 6 | Kharabi Darius | Chief BUSINESS Off | — | $17.3K |
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-10-24 | 2025-10-22+ | KALA | KALA BIO, Inc. | Reumuth Mary | CFO | S - Sale | $0.8297 | -33.2K | 29.9K | -53% | -$27.5K |
| 2025-06-26 | 2025-06-24 | KALA | KALA BIO, Inc. | Reumuth Mary | CFO | S - Sale | $4.01 | -3,631 | 62.1K | -6% | -$14.6K | |
| 2025-06-04 | 2025-06-03 | KALA | KALA BIO, Inc. | Reumuth Mary | CFO | S - Sale | $3.74 | -2,850 | 65.7K | -4% | -$10.7K | |
| D | 2025-01-07 | 2025-01-06 | KALA | KALA BIO, Inc. | Reumuth Mary | CFO | A - Grant | $0.00 | +10.1K | 70.3K | +17% | $0 |
| D | 2025-01-07 | 2025-01-06 | KALA | KALA BIO, Inc. | Reumuth Mary | CFO | S - Sale | $7.63 | -1,706 | 68.6K | -2% | -$13.0K |
| 2024-06-27 | 2024-06-26 | KALA | KALA BIO, Inc. | Reumuth Mary | CFO | S - Sale | $4.75 | -4,163 | 60.2K | -6% | -$19.8K | |
| 2024-06-03 | 2024-05-31 | KALA | KALA BIO, Inc. | Reumuth Mary | CFO | S - Sale | $6.09 | -1,786 | 64.3K | -3% | -$10.9K | |
| D | 2024-01-05 | 2024-01-04 | KALA | KALA BIO, Inc. | Reumuth Mary | CFO | A - Grant | $0.00 | +4,600 | 67.4K | +7% | $0 |
| D | 2024-01-05 | 2024-01-04 | KALA | KALA BIO, Inc. | Reumuth Mary | CFO | S - Sale | $6.74 | -1,227 | 66.1K | -2% | -$8,270 |
| D | 2023-06-23 | 2023-06-22 | KALA | KALA BIO, Inc. | Reumuth Mary | CFO | A - Grant | $0.00 | +36.1K | 62.8K | +136% | $0 |
| D | 2023-06-02 | 2023-05-31 | KALA | KALA BIO, Inc. | Reumuth Mary | CFO | A - Grant | — | +14.7K | 26.6K | +124% | — |
| 2023-01-06 | 2023-01-04 | KALA | KALA BIO, Inc. | Reumuth Mary | CFO | A - Grant | $0.00 | +9,525 | 11.9K | +394% | $0 | |
| 2023-01-06 | 2023-01-04 | KALA | KALA BIO, Inc. | Reumuth Mary | CFO | S - Sale | $28.54 | -60 | 11.9K | -0.5% | -$1,712 | |
| 2022-10-28 | 2022-10-26 | KALA | KALA BIO, Inc. | Reumuth Mary | CFO | S - Sale | $6.51 | -194 | 2,418 | -7% | -$1,263 | |
| 2022-06-29 | 2022-06-27 | KALA | KALA BIO, Inc. | Reumuth Mary | CFO | S - Sale | $0.37 | -2,613 | 130.6K | -2% | -$966.81 | |
| D | 2022-01-05 | 2022-01-04 | KALA | KALA BIO, Inc. | Reumuth Mary | CFO | S - Sale | $1.30 | -2,850 | 133.2K | -2% | -$3,705 |
| 2021-10-28 | 2021-10-26 | KALA | KALA BIO, Inc. | Reumuth Mary | CFO | S - Sale | $1.80 | -9,449 | 136.1K | -6% | -$17.0K |
Purchase Sale Sale after option exercise All abbreviations